Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
Open Access
- 5 April 2017
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 19, 107-118
- https://doi.org/10.1016/j.ebiom.2017.03.045
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust
- WHO (SPHQ14-LOA-311)
- BMG (ZMVI5-2514NIK005)
- BMBF
- DZIF (TTU01.905)
- Wellcome Trust (SPHQ14-LOA-311)
- German Center for Infection Research (TTU01.905)
- German National Department for Education and Research
- Bundesministerium für Gesundheit (ZMVI5-2514NIK005)
This publication has 33 references indexed in Scilit:
- Comprehensive characterization of cellular immune responses following Ebola virus infectionThe Journal of Infectious Diseases, 2016
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strainScience, 2015
- Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responsesJCI Insight, 2015
- Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After NeedlestickJama-Journal Of The American Medical Association, 2015
- Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type ResponseThe Journal of Immunology, 2013
- Systems biology of vaccination for seasonal influenza in humansNature Immunology, 2011
- Modification of dendritic cells with interferon‐γ‐inducible protein‐10 gene to enhance vaccine potencyThe Journal of Gene Medicine, 2009
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal ruleNature Reviews Microbiology, 2009
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg virusesVaccine, 2008
- Effective Post-Exposure Treatment of Ebola InfectionPLoS Pathogens, 2007